Can we improve cancer outcomes through the use of robots? How can we commission services differently to reduce variation in cancer outcomes? How can we implement a new local model of care for head and neck cancers to improve outcomes? …
Luke Hounsome is the PHE Cancer Analytical Programme Manager. He coordinates the work of the highly skilled PHE cancer analysts to respond to internal and external priorities; always with the intention of improving care and outcomes for cancer patients. After completing his PhD in physics Luke took a career change as a public health analyst, before specialising in analysing the cancer registration data. He then specialised in urological cancers for several years; working with clinicians, charities and policy makers.
Some of the highlights from his work have been peer-reviewed publications on the effect of centralisation on outcomes of bladder cancer surgery; the lifetime risk of prostate cancer in Black men; and the use of bladder reconstruction surgery. He is a co-investigator on the Life After Prostate Cancer Diagnosis project, which is one of the largest surveys of people with cancer, to find out about the experience of men with prostate cancer in the years after treatment
Related content and links
About this blog
The official blog of the UK Health Security Agency, providing expert insight on the organisation's work and all aspects of health security.
- Can you get hay fever in February or is the pollen count too low? 23 February 2024
- How pathogen genomics could help us detect new health threats and improve vaccines 24 January 2024
- Should we be worried about the new COVID-19 variant? 15 January 2024